NZ203034A - 3-(1h-tetrazol-5-yl)-4(3h)-quinazolinone derivatives - Google Patents

3-(1h-tetrazol-5-yl)-4(3h)-quinazolinone derivatives

Info

Publication number
NZ203034A
NZ203034A NZ203034A NZ20303483A NZ203034A NZ 203034 A NZ203034 A NZ 203034A NZ 203034 A NZ203034 A NZ 203034A NZ 20303483 A NZ20303483 A NZ 20303483A NZ 203034 A NZ203034 A NZ 203034A
Authority
NZ
New Zealand
Prior art keywords
tetrazol
formula
methyl
give
quinazolinone
Prior art date
Application number
NZ203034A
Other languages
English (en)
Inventor
N P Peet
S Sunder
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Priority to NZ21087083A priority Critical patent/NZ210870A/en
Publication of NZ203034A publication Critical patent/NZ203034A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Adhesive Tapes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Materials For Photolithography (AREA)
NZ203034A 1982-01-18 1983-01-14 3-(1h-tetrazol-5-yl)-4(3h)-quinazolinone derivatives NZ203034A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ21087083A NZ210870A (en) 1982-01-18 1983-01-14 Substituted 2-amino-n-(1h-tetrazol-5-yl)benzamide derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/340,577 US4419357A (en) 1982-01-18 1982-01-18 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones

Publications (1)

Publication Number Publication Date
NZ203034A true NZ203034A (en) 1985-09-13

Family

ID=23333997

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ203034A NZ203034A (en) 1982-01-18 1983-01-14 3-(1h-tetrazol-5-yl)-4(3h)-quinazolinone derivatives

Country Status (18)

Country Link
US (1) US4419357A (da)
EP (1) EP0086340B1 (da)
JP (1) JPS58124783A (da)
KR (1) KR880002358B1 (da)
AT (1) ATE18908T1 (da)
AU (2) AU555629B2 (da)
CA (1) CA1254204A (da)
DE (1) DE3362735D1 (da)
DK (1) DK159271C (da)
ES (1) ES8501758A1 (da)
GB (2) GB2113220B (da)
GR (1) GR77393B (da)
IE (1) IE54441B1 (da)
IL (1) IL67686A (da)
NO (1) NO830115L (da)
NZ (1) NZ203034A (da)
PH (1) PH18222A (da)
ZA (1) ZA83240B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
US4644065A (en) * 1984-05-15 1987-02-17 Merrell Dow Pharmaceuticals Inc. Process for the preparation of 4(3H)-quinazolinones
GB8429739D0 (en) * 1984-11-24 1985-01-03 Fbc Ltd Fungicides
US4761474A (en) * 1986-02-25 1988-08-02 Merrell Dow Pharmaceuticals Inc. 3-(1H-tetrazol-5-yl)thieno[2,3-d]pyrimidin-4(3H)-ones
US4757075A (en) * 1986-10-14 1988-07-12 Merrell Dow Pharmaceuticals Inc. Tetrazolylquinazolinones as anti-hyperuricemic agents
US8975288B2 (en) * 2012-04-10 2015-03-10 The Penn State Research Foundation F2 derivatives as antibacterial agents
HUE040316T2 (hu) * 2012-04-27 2019-02-28 Basf Se Helyettesített N-(tetrazol-5-il)- és N-(triazol-5-il)-aril-karboxamid vegyületek és ezek herbicidként történõ alkalmazása

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH364040A (fr) * 1960-04-19 1962-08-31 Ipa Anstalt Dispositif de détection pour vérifier si un élément d'une installation électrique est sous tension
US4035368A (en) * 1975-04-02 1977-07-12 Riker Laboratories, Inc. Substituted 3-(1H-tetrazol-5-yl)-quinoline compounds
GB1561350A (en) * 1976-11-05 1980-02-20 May & Baker Ltd Benzamide derivatives
AU508970B2 (en) * 1976-02-13 1980-04-17 Bristol-Myers Company Tetrazole derivatives
US4122274A (en) * 1977-05-25 1978-10-24 Bristol-Myers Company 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones
US4209620A (en) * 1978-06-19 1980-06-24 Bristol-Myers Company Substituted 3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives having antiallergy activity
NZ192392A (en) * 1978-12-19 1983-02-15 M Ishikawa 3-(substituted (phenyl or pyridyl)) -3,4-dihydroquinazolin-4-ones
GB2095240A (en) * 1981-03-05 1982-09-29 Fujisawa Pharmaceutical Co Dihydropyrimidine derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones

Also Published As

Publication number Publication date
DK159271C (da) 1991-02-18
JPS58124783A (ja) 1983-07-25
DK16783D0 (da) 1983-01-17
ATE18908T1 (de) 1986-04-15
DE3362735D1 (de) 1986-05-07
PH18222A (en) 1985-04-30
NO830115L (no) 1983-07-19
ES519005A0 (es) 1984-12-16
US4419357A (en) 1983-12-06
GB2113220A (en) 1983-08-03
GB2170800B (en) 1987-01-07
JPH0450310B2 (da) 1992-08-13
GB8300957D0 (en) 1983-02-16
CA1254204A (en) 1989-05-16
KR840003250A (ko) 1984-08-20
GB2170800A (en) 1986-08-13
IL67686A (en) 1985-12-31
AU1037783A (en) 1983-07-28
DK159271B (da) 1990-09-24
KR880002358B1 (ko) 1988-10-29
EP0086340B1 (en) 1986-04-02
GB2113220B (en) 1985-09-04
AU570852B2 (en) 1988-03-24
DK16783A (da) 1983-07-19
AU555629B2 (en) 1986-10-02
IE54441B1 (en) 1989-10-11
ES8501758A1 (es) 1984-12-16
GR77393B (da) 1984-09-11
GB8428402D0 (en) 1984-12-19
ZA83240B (en) 1983-10-26
IL67686A0 (en) 1983-05-15
IE830078L (en) 1983-07-18
EP0086340A1 (en) 1983-08-24
AU6151786A (en) 1986-12-11

Similar Documents

Publication Publication Date Title
DE2740588A1 (de) Imidazo- eckige klammer auf 1,2-a eckige klammer zu -chinolin-2-carbon- saeuren und deren derivate sowie pharmazeutische zubereitungen, die diese verbindungen enthalten
EP0086340B1 (en) 3-(1h-tetrazol-5-yl)-4(3h)-quinazolinones
US4735948A (en) (1H-tetrazol-5-yl)-2(1H)-quinolinones and-naphthyridones and antiallergic use thereof
US4816459A (en) Tetrazolyl-substituted pyrido[1,2-a]pyrimidines and use as SRS-A antagonists
US4192944A (en) Optionally substituted 4-oxo-4H-pyrido[1,2-a]pyrimidine-3-N-(1H-tetrazol-4-yl)carboxamides and their use as antiallergy agents
US4496569A (en) Antiallergic (1H-tetrazol-5-yl)tetrazolo[1,5-a]quinolines and derivatives thereof
US4798832A (en) Pyrido[1,2-a]pyrimidine compounds, corresponding intermediates and use as SRS-A antagonists
HU189898B (en) Process for the production of 1,2,3-triazino/4',5:4,5/ thieno/2,3-b/quinoline-h-/3h/-on-derivatives
NZ210870A (en) Substituted 2-amino-n-(1h-tetrazol-5-yl)benzamide derivatives
IE43028B1 (en) Substituted pyrimido-quinoline derivatives and pharmaceutical compositions containing them
EP0132788B1 (en) 2-(formylamino)-n-(1h-tetrazol-5-yl)benzamide
US4761474A (en) 3-(1H-tetrazol-5-yl)thieno[2,3-d]pyrimidin-4(3H)-ones
NZ209405A (en) Heterocyclic oxamic acids and pharmaceutical compositions
US4593099A (en) (Tetrazolyl) thienopyridinones
EP0210648A1 (en) 5-chloro-s-triazolo/4,3-a/pyridine-7-carboxylic acids
JPS61112082A (ja) テトラゾロチエノピリジン類